OTCMKTS:ECIA Encision (ECIA) Stock Price, News & Analysis $0.42 0.00 (0.00%) As of 05/7/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About Encision Stock (OTCMKTS:ECIA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Encision alerts:Sign Up Key Stats Today's Range$0.42▼$0.4250-Day Range$0.38▼$0.4952-Week Range$0.12▼$0.57VolumeN/AAverage Volume5,077 shsMarket Capitalization$4.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.Read More… Receive ECIA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Encision and its competitors with MarketBeat's FREE daily newsletter. Email Address ECIA Stock News HeadlinesEncision, Inc.: Encision Reports Third Quarter Fiscal Year 2025 ResultsFebruary 15, 2025 | finanznachrichten.deEncision, Inc.: Encision Reports Second Quarter Fiscal Year 2025 ResultsNovember 15, 2024 | finanznachrichten.deTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.May 8, 2025 | Porter & Company (Ad)Encision Inc (ECIA)September 1, 2024 | uk.investing.comEncision, Inc.: Encision Reports First Quarter Fiscal Year 2025 ResultsAugust 16, 2024 | finanznachrichten.deEncision Inc. (ECIA) Stock Historical Prices & Data - Yahoo FinanceMarch 1, 2024 | finance.yahoo.comEncision, Inc.: Encision Reports Third Quarter Fiscal Year 2024 ResultsFebruary 14, 2024 | finanznachrichten.deEncision Reports Third Quarter Fiscal Year 2024 ResultsFebruary 14, 2024 | finance.yahoo.comSee More Headlines ECIA Stock Analysis - Frequently Asked Questions How have ECIA shares performed this year? Encision's stock was trading at $0.45 at the beginning of the year. Since then, ECIA stock has decreased by 6.7% and is now trading at $0.42. View the best growth stocks for 2025 here. How were Encision's earnings last quarter? Encision Inc. (OTCMKTS:ECIA) released its quarterly earnings data on Thursday, May, 14th. The medical device company reported ($0.01) earnings per share for the quarter. The medical device company had revenue of $1.78 million for the quarter. Encision had a negative net margin of 8.96% and a negative trailing twelve-month return on equity of 32.90%. How do I buy shares of Encision? Shares of ECIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Encision own? Based on aggregate information from My MarketBeat watchlists, some other companies that Encision investors own include Akers Biosciences (AKER), MGT Capital Investments (MGTI), Brainstorm Cell Therapeutics (BCLI), Aviat Networks (AVNW), Activision Blizzard (ATVI), ATI (ATI) and Digital Turbine (APPS). Company Calendar Last Earnings5/14/2020Today5/08/2025Next Earnings (Estimated)7/14/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolOTCMKTS:ECIA CIK930775 Webwww.encision.com Phone(303) 444-2600Fax303-444-2693Employees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-690,000.00 Net Margins-8.96% Pretax Margin-7.85% Return on Equity-32.90% Return on Assets-15.51% Debt Debt-to-Equity Ratio0.11 Current Ratio1.67 Quick Ratio0.98 Sales & Book Value Annual Sales$6.59 million Price / Sales0.76 Cash FlowN/A Price / Cash FlowN/A Book Value$0.14 per share Price / Book3.00Miscellaneous Outstanding Shares11,880,000Free Float7,514,000Market Cap$4.99 million OptionableNot Optionable Beta0.69 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (OTCMKTS:ECIA) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersIt may already be too late… A global energy shift is underway—and lithium is at the center of it. From electric vehicles to grid storage a...Huge Alerts | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Encision Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Encision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.